VALOR Phase II (Stroke Recovery)

Purpose of this Study

We are doing this study to test an experimental program called VALOR. The VALOR program is designed to help people recovering from a stroke receive therapy for their arms at home using telehealth. It uses special virtual reality (VR) headsets and software to guide them through daily activities and tasks. The goal of the VALOR program is to see how well its therapy helps people recover arm movement after a stroke and to gather evidence on how easy it is to use and how much people like it. We hope that using VALOR for arm exercises at home will:
  • Improve arm movement in adults who have had a stroke
  • Work better than the usual care treatment
  • Be easy to use and well-liked by stroke survivors, with few cases of feeling sick from the technology

Who Can Participate?

Eligibility

Adults ages 18+ who:
  • Had a stroke on either the right or left side of the brain that affected their hand function
  • Had their stroke at least 3 months before joining the study
  • Can bend at least one finger enough for a therapist to see
  • Have vision of 20/50 or better with glasses or contacts
For more information, contact the study team at kelley.seebeck@duke.edu.

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

This study will last for approximately 25-weeks. It will involve four study visits, using the VR system to practice activities of daily living, a series of motor function tests, and questionnaires. If you choose to take part, you will get a random assignment (like a coin flip) to 1 of 2 study groups, which will be to either participate in the VALOR program or follow the standard home exercise plan that is used for stroke recovery.

Locations

Other

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

The Virtual Activities of Living for Occupational Rehabilitation (VALOR) Phase II

Principal Investigator

Jody
Feld

Protocol Number

PRO00116975

Phase

II

Enrollment Status

Pending Open to Enrollment